SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-021014
Filing Date
2024-05-22
Accepted
2024-05-22 16:15:21
Documents
15
Period of Report
2024-05-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39293
2 ex3-1.htm EX-3.1 10890
3 ex99-1.htm EX-99.1 12847
  Complete submission text file 0001493152-24-021014.txt   246618

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE thar-20240522.xsd EX-101.SCH 3021
5 XBRL LABEL FILE thar-20240522_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE thar-20240522_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3908
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41210 | Film No.: 24973447
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)